Qiagen NV (QGEN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

QGEN Qiagen NV

Watchlist

42.330
+0.240+0.57%

Close Nov 21 16:00 ET

42.580
+0.250+0.59%

Pre 07:07 ET

9.41BMarket Cap105.83P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Morgan Stanley Lists Hedge Funds' Largest Q3 Ownership Increases in Russell 1000 Stocks
Seeking AlphaNov 20 10:13 ET
Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022
BenzingaNov 18 07:34 ET
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
Seeking AlphaNov 15 15:00 ET
QGEN Collaborates With McGill University Centre: Stock to Gain?
Zacks Nov 13 10:35 ET
QIAGEN Collaborates With McGill University to Advance Microbiome Research
GlobeNewswireNov 12 16:05 ET
UBS Maintains Qiagen NV(QGEN.US) With Hold Rating
Moomoo NewsNov 11 08:31 ET · Ratings

Comments

Lnova

Nov 17 15:34

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
Article from late September…
forensic genealogy
$Qiagen NV (QGEN.US)$

Moomoo AI

Jan 8 08:29

Qiagen's high P/E ratio is worrisome due to its poor earnings forecast. Despite the high P/E, investors retain their shares, but this earnings growth rate may eventually impact the share price. The high P/E and future earnings predictions pose a substantial risk to shareholders and potential investors.

There's Reason For Concern Over Qiagen N.V.'s (NYSE:QGEN) Price

Moomoo AI

Dec 24, 2023 06:27

Qiagen's performance is strong due to strategic profit reinvestment, leading to significant earnings growth. Its respectable ROE contributes to a net income increase. Yet, forecasts anticipate a slowdown in future earnings growth.